A genetic test for baldness has been developed by PharmaGenoma, Inc. and its subsidiary HairDX, LLC. The test goes by the name of HairDX and it's available through a qualified physician. It claims to be able to predict signs of baldness in approximately 70% of men.
If a test shows up positive, a physician is able to tell a man that he has up to an 80% chance of going bald. If the test turns out to be negative the physician will be able to tell the individual that he has up to a 90% chance of not developing hair loss.
This genetic test looks for several gene variants associated with male pattern baldness, including markers on the Androgen Receptor (AR) gene as well as on Chromosome 20.The test is also available for women and can reveal androgen sensitivity.